Tasha Ahmad1,2, Steven R Laviolette3,4,5,6,7. 1. Addiction Research Group, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N5Y 5T8, Canada. 2. Department of Anatomy and Cell Biology, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N5Y 5T8, Canada. 3. Addiction Research Group, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N5Y 5T8, Canada. steven.laviolette@schulich.uwo.ca. 4. Department of Anatomy and Cell Biology, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N5Y 5T8, Canada. steven.laviolette@schulich.uwo.ca. 5. Department of Psychiatry, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N5Y 5T8, Canada. steven.laviolette@schulich.uwo.ca. 6. Department of Psychology, The Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, N5Y 5T8, Canada. steven.laviolette@schulich.uwo.ca. 7. Department of Anatomy and Cell Biology, University of Western Ontario, London, ON, N6A 5C1, Canada. steven.laviolette@schulich.uwo.ca.
Abstract
RATIONALE: The ventral tegmental area (VTA) and its projections to the basolateral amygdala (BLA) and nucleus accumbens (NAc) are critical for cannabinoid-related motivational effects. Cannabinoid CB1 receptor (CB1R) transmission modulates VTA dopamine (DA) neuron activity and previous reports demonstrate anatomically segregated effects of CB1R transmission in the VTA. However, the underlying pharmacological and anatomical regions responsible for these effects are currently unknown. OBJECTIVES: The objective of the study is to characterize the motivational effects of localized anterior vs. posterior intra-VTA activation vs. blockade of CB1R transmission and the potential role of intra-BLA and intra-NAc DA transmission in these phenomena. METHODS: Using a conditioned place preference (CPP) procedure, we administered a CB1 agonist (WIN-55,212-2) or antagonist (AM 251) into the posterior VTA (pVTA) or anterior VTA (aVTA) of rats, combined with intra-BLA or intra-NAc DA receptor blockade and intra-VTA co-administration of selective mu vs. kappa opiate-receptor antagonists. RESULTS: Intra-pVTA CB1R activation produced robust rewarding effects through a mu-opiate receptor mechanism whereas CB1R blockade produced conditioned place aversions (CPA) through a kappa-opiate receptor substrate. In contrast, modulation of aVTA CB1R transmission produced no observable effects. Intra-BLA DA receptor blockade prevented the rewarding effects of pVTA CB1R activation, but had no effects on CB1R blockade-induced aversions. In contrast, intra-NAc DA receptor blockade selectively blocked the aversive effects of pVTA CB1R antagonism. CONCLUSIONS: Activation vs. blockade of CB1R transmission in the posterior VTA produces bivalent rewarding or aversive effects through separate mu vs. kappa-opiate receptor substrates. These dissociable effects depend on separate DA receptor transmission substrates in the BLA or NAc, respectively.
RATIONALE: The ventral tegmental area (VTA) and its projections to the basolateral amygdala (BLA) and nucleus accumbens (NAc) are critical for cannabinoid-related motivational effects. CannabinoidCB1 receptor (CB1R) transmission modulates VTA dopamine (DA) neuron activity and previous reports demonstrate anatomically segregated effects of CB1R transmission in the VTA. However, the underlying pharmacological and anatomical regions responsible for these effects are currently unknown. OBJECTIVES: The objective of the study is to characterize the motivational effects of localized anterior vs. posterior intra-VTA activation vs. blockade of CB1R transmission and the potential role of intra-BLA and intra-NAc DA transmission in these phenomena. METHODS: Using a conditioned place preference (CPP) procedure, we administered a CB1 agonist (WIN-55,212-2) or antagonist (AM 251) into the posterior VTA (pVTA) or anterior VTA (aVTA) of rats, combined with intra-BLA or intra-NAc DA receptor blockade and intra-VTA co-administration of selective mu vs. kappa opiate-receptor antagonists. RESULTS: Intra-pVTA CB1R activation produced robust rewarding effects through a mu-opiate receptor mechanism whereas CB1R blockade produced conditioned place aversions (CPA) through a kappa-opiate receptor substrate. In contrast, modulation of aVTA CB1R transmission produced no observable effects. Intra-BLA DA receptor blockade prevented the rewarding effects of pVTA CB1R activation, but had no effects on CB1R blockade-induced aversions. In contrast, intra-NAc DA receptor blockade selectively blocked the aversive effects of pVTA CB1R antagonism. CONCLUSIONS: Activation vs. blockade of CB1R transmission in the posterior VTA produces bivalent rewarding or aversive effects through separate mu vs. kappa-opiate receptor substrates. These dissociable effects depend on separate DA receptor transmission substrates in the BLA or NAc, respectively.
Authors: Miriam Melis; Claudia Sagheddu; Marta De Felice; Alberto Casti; Camilla Madeddu; Saturnino Spiga; Anna Lisa Muntoni; Kenneth Mackie; Giovanni Marsicano; Giancarlo Colombo; Maria Paola Castelli; Marco Pistis Journal: J Neurosci Date: 2014-09-17 Impact factor: 6.167
Authors: M A De Luca; Z Bimpisidis; M Melis; M Marti; P Caboni; V Valentini; G Margiani; N Pintori; I Polis; G Marsicano; L H Parsons; G Di Chiara Journal: Neuropharmacology Date: 2015-10-23 Impact factor: 5.250
Authors: Christopher Norris; Michael Loureiro; Cecilia Kramar; Jordan Zunder; Justine Renard; Walter Rushlow; Steven R Laviolette Journal: Neuropsychopharmacology Date: 2016-06-14 Impact factor: 7.853
Authors: Mariana I Holubiec; Juan I Romero; Juan Suárez; Manuel Portavella; Emilio Fernández-Espejo; Eduardo Blanco; Pablo Galeano; Fernando Rodríguez de Fonseca Journal: Psychopharmacology (Berl) Date: 2018-07-29 Impact factor: 4.530
Authors: Sam Z Bacharach; Helen M Nasser; Natalie E Zlebnik; Hannah M Dantrassy; Daniel E Kochli; Utsav Gyawali; Joseph F Cheer; Donna J Calu Journal: Psychopharmacology (Berl) Date: 2018-08-14 Impact factor: 4.530
Authors: Christopher Norris; Hanna J Szkudlarek; Brian Pereira; Walter Rushlow; Steven R Laviolette Journal: Sci Rep Date: 2019-07-05 Impact factor: 4.379